Viewing Study NCT00867061


Ignite Creation Date: 2025-12-24 @ 11:59 AM
Ignite Modification Date: 2026-02-26 @ 11:14 AM
Study NCT ID: NCT00867061
Status: WITHDRAWN
Last Update Posted: 2017-06-23
First Post: 2009-03-19
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of 5-day Dosing of ON 01910.Na in Intermediate-1,-2, or High Risk Myelodysplastic Syndrome (MDS)
Sponsor: Traws Pharma, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Myelodysplastic Syndrome View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Myelodysplastic View
None IPSS Intermediate 1 View
None IPSS Intermediate 2 View
None IPSS High risk View